JG Credibility, page-9

First 9 Last

Share
Profile

Follow
Merchant2000

25,022 Posts.

986

20/06/18

10:57

Post #: 33820698
Share

Originally posted by harvett ↑

I don't think they had a tough time recruiting patient. There was only nine dose chorts and because they run into...well it seems like no real toxicity issues, they only needed 9 patients, to run up to the max 20mg dose. After that it would seem they lost some patients with death or none evable reasons. Read between the lines. Low toxicity and patients going the whole 8 cycles or 6 months. In other words they had a great start and only needed the lower numbers but at the end those NE reduced the numbers down to 5 which is meaningless and thus the need for more again. Yes I think that stuffed up but for a good reason.

Expand

IMO, This is the nature of all biotechs burning hundreds of millions of dollars over their lifetimes to try and find the holy grail - at shareholders hard-earned expense

The Cash Burn continues etc...…

The Silence continues etc....

DYOR

KZA Price at posting: 53.0¢ Sentiment: None Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

PSC

Prospect's Mumbezhi Project puts it at the middle of copper's megatrend. And FQM just bought in

NWC

New World board urges holders to accept Kinterra's now-uncontested takeover bid

TYP

Tryptamine enrolling binge eaters for magic mushrooms study

PTX

This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution

First 9 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

JG Credibility, page-9

Top Stories

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

Prospect's Mumbezhi Project puts it at the middle of copper's megatrend. And FQM just bought in

New World board urges holders to accept Kinterra's now-uncontested takeover bid

Tryptamine enrolling binge eaters for magic mushrooms study

This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution

Featured News